First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas
首创的无转录激活因子、强力霉素诱导的 IL-18 工程化 CAR-T 细胞,用于治疗复发/难治性 B 细胞淋巴瘤
期刊:Molecular Therapy-Nucleic Acids
影响因子:6.5
doi:10.1016/j.omtn.2024.102308
Pedro Justicia-Lirio, María Tristán-Manzano, Noelia Maldonado-Pérez, Carmen Barbero-Jiménez, Marina Cortijo-Gutiérrez, Kristina Pavlovic, Francisco J Molina-Estevez, Pilar Muñoz, Ana Hinckley-Boned, Juan R Rodriguez-Madoz, Felipe Prosper, Carmen Griñán-Lison, Saúl A Navarro-Marchal, Carla Panisello,